Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.
By M. Ryan, Patrick Collins, J. Thakore. American Journal of Psychiatry, 2003
879 citations recorded by the source corpus.
Subfields: Behavioral Neuroscience, Biological Psychiatry, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/eac49cffed5ac727cc4132e5ebd77a3b3bedc50f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
Citations in the corpus
- Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis (2006, positive): “For example, Cushing ’ s syndrome, sleeping disorders, work stress and schizophrenia [30 – 33] appeared to be associated with an increased level of cortisol and also with an increased risk of type 2 diabetes and insulin resistance, although studies on sleep disorders showed inconsistent results…”
- Physical illness and schizophrenia: a review of the literature (2007, background): “There are a few studies of patients who did not receive antipsychotic medications, suggesting that schizophrenia itself is associated with altered glucose metabolism, but these studies were too small to be anything but hypothesis generating (232, 238).”
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012, background): “Schizophrenia itself is an independent risk-factor for developing diabetes mellitus and hyperlipidemia (Bushe and Holt 2004; Colton and Manderscheid 2006; Henderson et al. 2005; Newcomer 2007; Ryan et al. 2003).”